XTL Biopharmaceuticals Ltd. Logo

XTL Biopharmaceuticals Ltd.

Acquires and develops late-stage drugs for unmet medical needs, focusing on autoimmune diseases.

XTLB | TA

Overview

Corporate Details

ISIN(s):
IL0010854979
LEI:
529900NDDXEAPTUTXP41
Country:
Israel
Address:
5 HaCharoshet St., 4365603 Raanana
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of late-stage pharmaceutical product candidates. The company's primary strategy is to identify and advance proprietary drugs for the treatment of unmet medical needs, with a particular focus on autoimmune diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-29 08:54
Foreign Filer Report
Immediate Report
English 110.3 KB
2025-07-29 08:54
Foreign Filer Report
Immediate Report
English 36.4 KB
2025-07-24 00:45
Pre-Annual General Meeting Information
Immediate Report
English 112.7 KB
2025-07-24 00:45
Foreign Filer Report
Immediate Report
English 36.4 KB
2025-06-15 11:36
Board/Management Information
Immediate Report of Meeting to be held on July 21, 2025
English 735.8 KB
2025-06-15 11:36
Foreign Filer Report
Immediate Report of Meeting to be held on July 21, 2025
English 262.4 KB
2025-06-15 11:36
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on July 21, 2025
English 131.2 KB
2025-05-01 01:18
Foreign Filer Report
FORM 20-F For the fiscal year ended December 31, 2024
English 5.4 MB
2025-05-01 01:18
Foreign Filer Report
FORM 20-F For the fiscal year ended December 31, 2024
English 36.3 KB
2025-04-07 18:27
Board/Management Information
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo S…
English 141.8 KB
2025-04-07 18:27
Foreign Filer Report
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo S…
English 36.3 KB
2025-03-04 14:39
Foreign Filer Report
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated …
English 116.4 KB
2025-03-04 14:39
Foreign Filer Report
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated …
English 36.3 KB
2025-02-04 00:17
Foreign Filer Report
. Tal Klinger’s and Yair Redl’s decisions to resign from the Board were not due…
English 111.2 KB
2025-02-04 00:17
Foreign Filer Report
. Tal Klinger’s and Yair Redl’s decisions to resign from the Board were not due…
English 36.3 KB

Automate Your Workflow. Get a real-time feed of all XTL Biopharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for XTL Biopharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.